Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

Publication date: Available online 14 April 2021Source: The Lancet Respiratory MedicineAuthor(s): Tracy J Ruckwardt, Kaitlyn M Morabito, Emily Phung, Michelle C Crank, Pamela J Costner, LaSonji A Holman, Lauren A Chang, Somia P Hickman, Nina M Berkowitz, Ingelise J Gordon, Galina V Yamshchikov, Martin R Gaudinski, Bob Lin, Robert Bailer, Man Chen, Ana M Ortega-Villa, Thuy Nguyen, Azad Kumar, Richard M Schwartz, Lisa A Kueltzo
Source: The Lancet Respiratory Medicine - Category: Respiratory Medicine Source Type: research